Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score …

B Schrage, A Uijl, L Benson, D Westermann… - Circulation, 2019 - Am Heart Assoc
Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention

PS Chan, BK Nallamothu, JA Spertus… - … Quality and Outcomes, 2009 - Am Heart Assoc
Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population

WC Levy, KL Lee, AS Hellkamp, JE Poole… - Circulation, 2009 - Am Heart Assoc
Background—Although implantable cardioverter-defibrillator (ICD) therapy reduces mortality
in moderately symptomatic heart failure patients with an ejection fraction≤ 35%, many such …

Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure

MB Elming, JC Nielsen, J Haarbo, L Videbæk… - Circulation, 2017 - Am Heart Assoc
Background: The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable
Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) …

Long-term follow-up of DANISH (the Danish study to assess the efficacy of ICDs in patients with nonischemic systolic heart failure on mortality)

A Yafasova, JH Butt, MB Elming, JC Nielsen, J Haarbo… - Circulation, 2022 - Am Heart Assoc
Background: DANISH (The Danish Study to Assess the Efficacy of Implantable Cardioverter
Defibrillators [ICDs] in Patients With Nonischemic Systolic Heart Failure on Mortality) found …

Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials

BA Steinberg, SM Al-Khatib, R Edwards, JY Han… - JACC: Heart Failure, 2014 - jacc.org
Objectives: The aim of this study was to determine if the benefit of implantable cardioverter-
defibrillators (ICDs) is modulated by medical comorbidity. Background: Primary prevention …

Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 …

MJ Shun-Shin, SL Zheng, GD Cole… - European heart …, 2017 - academic.oup.com
Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the sudden cardiac …

S Adabag, KK Patton, AE Buxton, TS Rector… - JAMA …, 2017 - jamanetwork.com
Importance Improvement in left ventricular ejection fraction (EF) to> 35% occurs in many
patients with reduced EF at baseline. To our knowledge, whether implantable cardioverter …

Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the DANISH trial

SL Kristensen, WC Levy, R Shadman, JC Nielsen… - JACC: Heart Failure, 2019 - jacc.org
Objectives: This study aims to identify patients with nonischemic heart failure who are more
likely to benefit from implantable cardioverter-defibrillator (ICD) implantation by use of …

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study

MT Koller, B Schaer, M Wolbers, C Sticherling… - Circulation, 2008 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs) improve survival in selected
patients with left ventricular systolic dysfunction in randomized trials. Competing death …